Erin Lavelle
CIK 1737613 · COO & CFO · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
11
Lifetime Open-Market Net
-$19.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JBIO | Director | — | $15.34 | — | $0 | 2 | 2026-06-11 |
| AVLN | Director | — | — | — | $0 | 1 | 2026-05-01 |
| Neurogene Inc. (NLTX) Delisted | Director | — | $13.96 | — | $0 | 2 | 2023-06-09 |
| Climb Bio, Inc. (ELYM) Delisted | COO & CFO | — | $5.11 | — | $0 | 2 | 2022-11-02 |
| ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Chief Operating Officer | 4,408 | — | — | -$19.6K | 3 | 2019-04-25 |
Recent Filings · Page 2 of 2
11 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-04-18 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–11 of 11
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.